[1] |
DIXON SJ, LEMBERG KM, LAMPRECHT MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149( 5): 1060- 1072. DOI: 10.1016/j.cell.2012.03.042.
|
[2] |
GALLUZZI L, VITALE I, AARONSON SA, et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018[J]. Cell Death Differ, 2018, 25( 3): 486- 541. DOI: 10.1038/s41418-017-0012-4.
|
[3] |
YANG WS, SRIRAMARATNAM R, WELSCH ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156( 1-2): 317- 331. DOI: 10.1016/j.cell.2013.12.010.
|
[4] |
CHEN X, KANG R, KROEMER G, et al. Broadening horizons: The role of ferroptosis in cancer[J]. Nat Rev Clin Oncol, 2021, 18( 5): 280- 296. DOI: 10.1038/s41571-020-00462-0.
|
[5] |
CHELI VT, CORREALE J, PAEZ PM, et al. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination[J]. ASN Neuro, 2020, 12: 1759091420962681. DOI: 10.1177/1759091420962681.
|
[6] |
YAMADA N, KARASAWA T, WAKIYA T, et al. Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis[J]. Am J Transplant, 2020, 20( 6): 1606- 1618. DOI: 10.1111/ajt.15773.
|
[7] |
WU LY, LU XL. Research advances in ferroptosis in the pathogenesis and treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2023, 39( 7): 1687- 1695. DOI: 10.3969/j.issn.1001-5256.2023.07.025.
吴龙云, 鲁晓岚. 铁死亡在非酒精性脂肪性肝病发病和治疗中的作用[J]. 临床肝胆病杂志, 2023, 39( 7): 1687- 1695. DOI: 10.3969/j.issn.1001-5256.2023.07.025.
|
[8] |
HIRAO H, NAKAMURA K, KUPIEC-WEGLINSKI JW. Liver ischaemia-reperfusion injury: A new understanding of the role of innate immunity[J]. Nat Rev Gastroenterol Hepatol, 2022, 19( 4): 239- 256. DOI: 10.1038/s41575-021-00549-8.
|
[9] |
URSINI F, MAIORINO M. Lipid peroxidation and ferroptosis: The role of GSH and GPx4[J]. Free Radic Biol Med, 2020, 152: 175- 185. DOI: 10.1016/j.freeradbiomed.2020.02.027.
|
[10] |
DODSON M, CASTRO-PORTUGUEZ R, ZHANG DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis[J]. Redox Biol, 2019, 23: 101107. DOI: 10.1016/j.redox.2019.101107.
|
[11] |
TANG DL, CHEN X, KANG R, et al. Ferroptosis: Molecular mechanisms and health implications[J]. Cell Res, 2021, 31( 2): 107- 125. DOI: 10.1038/s41422-020-00441-1.
|
[12] |
ZHANG Y, TAN H, DANIELS JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model[J]. Cell Chem Biol, 2019, 26( 5): 623- 633. DOI: 10.1016/j.chembiol.2019.01.008.
|
[13] |
LI SB, HE YP, CHEN KX, et al. RSL3 drives ferroptosis through NF-κB pathway activation and GPX4 depletion in glioblastoma[J]. Oxid Med Cell Longev, 2021, 2021: 2915019. DOI: 10.1155/2021/2915019.
|
[14] |
GASCHLER MM, ANDIA AA, LIU HR, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation[J]. Nat Chem Biol, 2018, 14( 5): 507- 515. DOI: 10.1038/s41589-018-0031-6.
|
[15] |
SUN YD, BERLETH N, WU WX, et al. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells[J]. Cell Death Dis, 2021, 12( 11): 1028. DOI: 10.1038/s41419-021-04306-2.
|
[16] |
CHEN GW, LI C, ZHANG L, et al. Hydroxysafflor yellow A and anhydrosafflor yellow B alleviate ferroptosis and parthanatos in PC12 cells injured by OGD/R[J]. Free Radic Biol Med, 2022, 179: 1- 10. DOI: 10.1016/j.freeradbiomed.2021.12.262.
|
[17] |
KIM KM, CHO SS, KI SH. Emerging roles of ferroptosis in liver pathophysiology[J]. Arch Pharm Res, 2020, 43( 10): 985- 996. DOI: 10.1007/s12272-020-01273-8.
|
[18] |
HIRAO H, NAKAMURA K, KUPIEC-WEGLINSKI JW. Liver ischaemia-reperfusion injury: A new understanding of the role of innate immunity[J]. Nat Rev Gastroenterol Hepatol, 2022, 19( 4): 239- 256. DOI: 10.1038/s41575-021-00549-8.
|
[19] |
DAR WA, SULLIVAN E, BYNON JS, et al. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms[J]. Liver Int, 2019, 39( 5): 788- 801. DOI: 10.1111/liv.14091.
|
[20] |
KALOGERIS T, BAINES CP, KRENZ M, et al. Cell biology of ischemia/reperfusion injury[J]. Int Rev Cell Mol Biol, 2012, 298: 229- 317. DOI: 10.1016/B978-0-12-394309-5.00006-7.
|
[21] |
LI J, LI RJ, LV GY, et al. The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury[J]. Eur Rev Med Pharmacol Sci, 2015, 19( 11): 2036- 2047.
|
[22] |
ABU-AMARA M, YANG SY, TAPURIA N, et al. Liver ischemia/reperfusion injury: Processes in inflammatory networks: A review[J]. Liver Transpl, 2010, 16( 9): 1016- 1032. DOI: 10.1002/lt.22117.
|
[23] |
DENG YZ, NI LH. Research progress on the mechanism and prevention strategies of hepatic ischemia-reperfusion injury[J]. Chin J Microcirc, 2023, 33( 2): 109- 115. DOI: 10.3969/j.issn.1005-1740.2023.02.020.
邓银芝, 倪利华. 肝脏缺血再灌注损伤的机制及防治策略的研究进展[J]. 微循环学杂志, 2023, 33( 2): 109- 115. DOI: 10.3969/j.issn.1005-1740.2023.02.020.
|
[24] |
GNAIGER E, KUZNETSOV AV, RIEGER G, et al. Mitochondrial defects by intracellular calcium overload versus endothelial cold ischemia/reperfusion injury[J]. Transpl Int, 2000, 13( Suppl 1): S555- S557. DOI: 10.1007/s001470050401.
|
[25] |
PERALTA C, JIMÉNEZ-CASTRO MB, GRACIA-SANCHO J. Hepatic ischemia and reperfusion injury: Effects on the liver sinusoidal milieu[J]. J Hepatol, 2013, 59( 5): 1094- 1106. DOI: 10.1016/j.jhep.2013.06.017.
|
[26] |
CHANG CK, ZHANG X, XIAO C, et al. Research advances of hepcidin expression and its regulation mechanism—Review[J]. J Exp Hematol, 2012, 20( 4): 1030- 1033.
常春康, 张曦, 肖超, 等. 铁调素的表达与调节机制研究进展[J]. 中国实验血液学杂志, 2012, 20( 4): 1030- 1033.
|
[27] |
WUNDERER F, TRAEGER L, SIGURSLID HH, et al. The role of hepcidin and iron homeostasis in atherosclerosis[J]. Pharmacol Res, 2020, 153: 104664. DOI: 10.1016/j.phrs.2020.104664.
|
[28] |
LUO LF, MO GH, HUANG DQ. Ferroptosis in hepatic ischemia-reperfusion injury: Regulatory mechanisms and new methods for therapy(Review)[J]. Mol Med Rep, 2021, 23( 3): 225. DOI: 10.3892/mmr.2021.11864.
|
[29] |
LING MY, YE L, ZENG Q, et al. Ferrostatin-1 alleviates ventilator-induced lung injury by inhibiting ferroptosis[J]. Int Immunopharmacol, 2023, 120: 110356. DOI: 10.1016/j.intimp.2023.110356.
|
[30] |
FANG XL, SHI JH, WANG JH, et al. The relationship between ferroptosis and inflammation[J]. Chin J Histochem Cytochem, 2023, 32( 2): 196- 201. DOI: 10.16705/j.cnki.1004-1850.2023.02.012.
方晓苓, 石建华, 王金海, 等. 铁死亡与炎症的关系[J]. 中国组织化学与细胞化学杂志, 2023, 32( 2): 196- 201. DOI: 10.16705/j.cnki.1004-1850.2023.02.012.
|
[31] |
LI YQ, XU HT, ZHAO WJ, et al. Ferroptosis and oxidative stress in hepatic cellular carcinoma[J]. Hans J Biomed, 2023, 9( 3): 293- 302.
李雅琪, 徐弘庭, 赵维坚, 等. 肝细胞癌中的铁死亡与氧化应激[J]. 生物医学, 2023, 9( 3): 293- 302.
|
[32] |
XIE Y, HOU W, SONG X, et al. Ferroptosis: Process and function[J]. Cell Death Differ, 2016, 23( 3): 369- 379. DOI: 10.1038/cdd.2015.158.
|
[33] |
MIOTTO G, ROSSETTO M, DI PAOLO ML, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1[J]. Redox Biol, 2020, 28: 101328. DOI: 10.1016/j.redox.2019.101328.
|
[34] |
SEO MY, LEE SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats[J]. J Hepatol, 2002, 36( 1): 72- 77. DOI: 10.1016/s0168-8278(01)00236-7.
|
[35] |
COTGREAVE IA. N-acetylcysteine: Pharmacological considerations and experimental and clinical applications[J]. Adv Pharmacol, 1997, 38: 205- 227.
|
[36] |
DULUNDU E, OZEL Y, TOPALOGLU U, et al. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats[J]. Pharmacology, 2007, 79( 3): 163- 170. DOI: 10.1159/000098953.
|
[37] |
GIAKOUSTIDIS DE, ILIADIS S, TSANTILAS D, et al. Blockade of Kupffer cells by gadolinium chloride reduces lipid peroxidation and protects liver from ischemia/reperfusion injury[J]. Hepatogastroenterology, 2003, 50( 53): 1587- 1592.
|
[38] |
WANG B, XU H, LI J, et al. Complement depletion with cobra venom factor alleviates acute hepatic injury induced by ischemia-reperfusion[J]. Mol Med Rep, 2018, 18( 5): 4523- 4529. DOI: 10.3892/mmr.2018.9484.
|
[39] |
FANG XX, ZHANG JW, LI Y, et al. Malic enzyme 1 as a novel anti-ferroptotic regulator in hepatic ischemia/reperfusion injury[J]. Adv Sci(Weinh), 2023, 10( 13): e2205436. DOI: 10.1002/advs. 202205436.
|
[40] |
GUO JW, SONG ZH, YU J, et al. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis[J]. Cell Death Dis, 2022, 13( 12): 1072. DOI: 10.1038/s41419-022-05518-w.
|
[41] |
WU Y, JIAO HK, YUE YB, et al. Ubiquitin ligase E3 HUWE1/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury[J]. Cell Death Differ, 2022, 29( 9): 1705- 1718. DOI: 10.1038/s41418-022-00957-6.
|
[42] |
WU LL, TIAN X, ZUO HW, et al. MiR-124-3p delivered by exosomes from heme oxygenase-1 modified bone marrow mesenchymal stem cells inhibits ferroptosis to attenuate ischemia-reperfusion injury in steatotic grafts[J]. J Nanobiotechnology, 2022, 20( 1): 196. DOI: 10.1186/s12951-022-01407-8.
|
[43] |
ZHONG C, YANG J, ZHANG YY, et al. TRPM2 mediates hepatic ischemia-reperfusion injury via Ca2+-induced mitochondrial lipid peroxidation through increasing ALOX12 expression[J]. Research(Wash D C), 2023, 6: 0159. DOI: 10.34133/research.0159.
|